FDA NDC Directory · JSON-LD · Markdown

mesalamine

NDC 70771-1071 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA091640
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (1.2 g/1)
Marketing started20170619
Package count2

External sources

Source: openFDA. Public-domain (CC0).